Copyright Reports & Markets. All rights reserved.

Global Treatment and Prevention of Herpes Labialis Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Valacyclovir
    • 1.2.3 Aciclovir
    • 1.2.4 Famciclovir
    • 1.2.5 Docosanol
    • 1.2.6 Other
  • 1.3 Market by Application
    • 1.3.1 Global Treatment and Prevention of Herpes Labialis Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 External Use
    • 1.3.3 Oral
    • 1.3.4 Injection
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Treatment and Prevention of Herpes Labialis Market Perspective (2016-2027)
  • 2.2 Treatment and Prevention of Herpes Labialis Growth Trends by Regions
    • 2.2.1 Treatment and Prevention of Herpes Labialis Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Treatment and Prevention of Herpes Labialis Historic Market Share by Regions (2016-2021)
    • 2.2.3 Treatment and Prevention of Herpes Labialis Forecasted Market Size by Regions (2022-2027)
  • 2.3 Treatment and Prevention of Herpes Labialis Industry Dynamic
    • 2.3.1 Treatment and Prevention of Herpes Labialis Market Trends
    • 2.3.2 Treatment and Prevention of Herpes Labialis Market Drivers
    • 2.3.3 Treatment and Prevention of Herpes Labialis Market Challenges
    • 2.3.4 Treatment and Prevention of Herpes Labialis Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue
    • 3.1.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue (2016-2021)
    • 3.1.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Players (2016-2021)
  • 3.2 Global Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Treatment and Prevention of Herpes Labialis Revenue
  • 3.4 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio
    • 3.4.1 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Treatment and Prevention of Herpes Labialis Revenue in 2020
  • 3.5 Treatment and Prevention of Herpes Labialis Key Players Head office and Area Served
  • 3.6 Key Players Treatment and Prevention of Herpes Labialis Product Solution and Service
  • 3.7 Date of Enter into Treatment and Prevention of Herpes Labialis Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Treatment and Prevention of Herpes Labialis Breakdown Data by Type

  • 4.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Type (2016-2021)
  • 4.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2022-2027)

5 Treatment and Prevention of Herpes Labialis Breakdown Data by Application

  • 5.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Application (2016-2021)
  • 5.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
  • 6.2 North America Treatment and Prevention of Herpes Labialis Market Size by Type
    • 6.2.1 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
    • 6.2.2 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
    • 6.2.3 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
  • 6.3 North America Treatment and Prevention of Herpes Labialis Market Size by Application
    • 6.3.1 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
    • 6.3.2 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
    • 6.3.3 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
  • 6.4 North America Treatment and Prevention of Herpes Labialis Market Size by Country
    • 6.4.1 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
    • 6.4.2 North America Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
  • 7.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Type
    • 7.2.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
    • 7.2.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
    • 7.2.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
  • 7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Application
    • 7.3.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
    • 7.3.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
    • 7.3.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
  • 7.4 Europe Treatment and Prevention of Herpes Labialis Market Size by Country
    • 7.4.1 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
    • 7.4.2 Europe Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
  • 8.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type
    • 8.2.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application
    • 8.3.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region
    • 8.4.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
  • 9.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type
    • 9.2.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
    • 9.2.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
    • 9.2.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
  • 9.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application
    • 9.3.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
    • 9.3.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
    • 9.3.3 Latin America Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
  • 9.4 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country
    • 9.4.1 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
    • 9.4.2 Latin America Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size (2016-2027)
  • 10.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type
    • 10.2.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application
    • 10.3.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country
    • 10.4.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 GSK
    • 11.1.1 GSK Company Details
    • 11.1.2 GSK Business Overview
    • 11.1.3 GSK Treatment and Prevention of Herpes Labialis Introduction
    • 11.1.4 GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.1.5 GSK Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Treatment and Prevention of Herpes Labialis Introduction
    • 11.2.4 Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Teva
    • 11.3.1 Teva Company Details
    • 11.3.2 Teva Business Overview
    • 11.3.3 Teva Treatment and Prevention of Herpes Labialis Introduction
    • 11.3.4 Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.3.5 Teva Recent Development
  • 11.4 Mylan
    • 11.4.1 Mylan Company Details
    • 11.4.2 Mylan Business Overview
    • 11.4.3 Mylan Treatment and Prevention of Herpes Labialis Introduction
    • 11.4.4 Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.4.5 Mylan Recent Development
  • 11.5 Cadila
    • 11.5.1 Cadila Company Details
    • 11.5.2 Cadila Business Overview
    • 11.5.3 Cadila Treatment and Prevention of Herpes Labialis Introduction
    • 11.5.4 Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.5.5 Cadila Recent Development
  • 11.6 Apotex
    • 11.6.1 Apotex Company Details
    • 11.6.2 Apotex Business Overview
    • 11.6.3 Apotex Treatment and Prevention of Herpes Labialis Introduction
    • 11.6.4 Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.6.5 Apotex Recent Development
  • 11.7 Daewoong Pharmaceutical
    • 11.7.1 Daewoong Pharmaceutical Company Details
    • 11.7.2 Daewoong Pharmaceutical Business Overview
    • 11.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Introduction
    • 11.7.4 Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.7.5 Daewoong Pharmaceutical Recent Development
  • 11.8 Livzon
    • 11.8.1 Livzon Company Details
    • 11.8.2 Livzon Business Overview
    • 11.8.3 Livzon Treatment and Prevention of Herpes Labialis Introduction
    • 11.8.4 Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.8.5 Livzon Recent Development
  • 11.9 Luoxin
    • 11.9.1 Luoxin Company Details
    • 11.9.2 Luoxin Business Overview
    • 11.9.3 Luoxin Treatment and Prevention of Herpes Labialis Introduction
    • 11.9.4 Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.9.5 Luoxin Recent Development
  • 11.10 Med shine
    • 11.10.1 Med shine Company Details
    • 11.10.2 Med shine Business Overview
    • 11.10.3 Med shine Treatment and Prevention of Herpes Labialis Introduction
    • 11.10.4 Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.10.5 Med shine Recent Development
  • 11.11 Bayer (Campho Phenique)
    • 11.11.1 Bayer (Campho Phenique) Company Details
    • 11.11.2 Bayer (Campho Phenique) Business Overview
    • 11.11.3 Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Introduction
    • 11.11.4 Bayer (Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.11.5 Bayer (Campho Phenique) Recent Development
  • 11.12 Blistex
    • 11.12.1 Blistex Company Details
    • 11.12.2 Blistex Business Overview
    • 11.12.3 Blistex Treatment and Prevention of Herpes Labialis Introduction
    • 11.12.4 Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.12.5 Blistex Recent Development
  • 11.13 Kelun Group
    • 11.13.1 Kelun Group Company Details
    • 11.13.2 Kelun Group Business Overview
    • 11.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Introduction
    • 11.13.4 Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.13.5 Kelun Group Recent Development
  • 11.14 Hikma
    • 11.14.1 Hikma Company Details
    • 11.14.2 Hikma Business Overview
    • 11.14.3 Hikma Treatment and Prevention of Herpes Labialis Introduction
    • 11.14.4 Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.14.5 Hikma Recent Development
  • 11.15 Haiwang
    • 11.15.1 Haiwang Company Details
    • 11.15.2 Haiwang Business Overview
    • 11.15.3 Haiwang Treatment and Prevention of Herpes Labialis Introduction
    • 11.15.4 Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.15.5 Haiwang Recent Development
  • 11.16 Carmex
    • 11.16.1 Carmex Company Details
    • 11.16.2 Carmex Business Overview
    • 11.16.3 Carmex Treatment and Prevention of Herpes Labialis Introduction
    • 11.16.4 Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.16.5 Carmex Recent Development
  • 11.17 Cipher
    • 11.17.1 Cipher Company Details
    • 11.17.2 Cipher Business Overview
    • 11.17.3 Cipher Treatment and Prevention of Herpes Labialis Introduction
    • 11.17.4 Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2016-2021)
    • 11.17.5 Cipher Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Treatment and Prevention of Herpes Labialis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Treatment and Prevention of Herpes Labialis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Valacyclovir
    Aciclovir
    Famciclovir
    Docosanol
    Other

    Segment by Application
    External Use
    Oral
    Injection

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    GSK
    Novartis
    Teva
    Mylan
    Cadila
    Apotex
    Daewoong Pharmaceutical
    Livzon
    Luoxin
    Mylan
    Cadila
    Blistex
    Kelun Group
    Hikma
    Haiwang
    Carmex

    Buy now